These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38124774)

  • 1. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Miyun District of Beijing, China: An EQ-5D survey.
    Zhao D; Suo L; Lu L; Pan J; Peng X; Wang Y; Pang X
    Vaccine X; 2023 Dec; 15():100415. PubMed ID: 38124774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
    Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
    BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Herpes Zoster and Post-Herpetic Neuralgia on Health-Related Quality of Life in Japanese Adults Aged 60 Years or Older: Results from a Prospective, Observational Cohort Study.
    Mizukami A; Sato K; Adachi K; Matthews S; Holl K; Matsuki T; Kaise T; Curran D
    Clin Drug Investig; 2018 Jan; 38(1):29-37. PubMed ID: 29086340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Herpes Zoster and Postherpetic Neuralgia on the Quality of Life in China: A Prospective Study.
    Liu Y; Liu H; Bian Q; Zhang S; Guan Y
    Clin Cosmet Investig Dermatol; 2024; 17():1905-1915. PubMed ID: 39220293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A follow-up study on the pain changes trend and effects in patients diagnosed with herpes zoster in Beijing City].
    Zhao D; Suo LD; Pan JB; Peng XH; Wang YF; Zhou T; Li XM; Ma Y; Li ZA; Pang XH; Lu L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):2068-2072. PubMed ID: 38186158
    [No Abstract]   [Full Text] [Related]  

  • 7. The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy.
    Matthews S; De Maria A; Passamonti M; Ristori G; Loiacono I; Puggina A; Curran D
    Open Forum Infect Dis; 2019 Feb; 6(2):ofz007. PubMed ID: 30793003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden and Impact on Quality of Life of Herpes Zoster in Spanish Adults Aged 50 Years or Older: A Prospective Cohort Study.
    Díez-Domingo J; Curran D; Cambronero MDR; Garcia-Martinez JA; Matthews S
    Adv Ther; 2021 Jun; 38(6):3325-3341. PubMed ID: 34013498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study.
    Serpell M; Gater A; Carroll S; Abetz-Webb L; Mannan A; Johnson R
    Health Qual Life Outcomes; 2014 Jun; 12():92. PubMed ID: 24920439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han R; Gomez JA; de Veras B; Pinto T; Guzman-Holst A; Nieto J; van Oorschot DAM
    Hum Vaccin Immunother; 2023 Dec; 19(1):2164144. PubMed ID: 36821856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
    Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
    BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and utility in immunocompromised subjects who developed herpes zoster during the randomized V212 inactivated varicella-zoster vaccine (ZV
    Eriksson J; Hunger M; Bourhis F; Thorén R; Popmihajlov Z; Finelli L; Jiang Y
    Expert Rev Pharmacoecon Outcomes Res; 2020 Dec; 20(6):613-621. PubMed ID: 31721601
    [No Abstract]   [Full Text] [Related]  

  • 13. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life.
    Johnson RW; Bouhassira D; Kassianos G; Leplège A; Schmader KE; Weinke T
    BMC Med; 2010 Jun; 8():37. PubMed ID: 20565946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
    Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
    PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B; Weidemann F; Reinhold T; Siedler A; Krause G; Wichmann O
    BMC Health Serv Res; 2013 Sep; 13():359. PubMed ID: 24070414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
    Brisson M; Pellissier JM; Camden S; Quach C; De Wals P
    Hum Vaccin; 2008; 4(3):238-45. PubMed ID: 18382137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized comparison of the efficacy of standard antiviral therapy versus ultrasound-guided thoracic paravertebral block for acute herpes zoster.
    Ma Y; Li B; Sun L; He X; Wu S; Shi F; Niu L
    Ann Med; 2022 Dec; 54(1):369-378. PubMed ID: 35107389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of herpes zoster vaccine in Canada.
    Najafzadeh M; Marra CA; Galanis E; Patrick DM
    Pharmacoeconomics; 2009; 27(12):991-1004. PubMed ID: 19908924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
    Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
    Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster in Germany: quantifying the burden of disease.
    Ultsch B; Siedler A; Rieck T; Reinhold T; Krause G; Wichmann O
    BMC Infect Dis; 2011 Jun; 11():173. PubMed ID: 21679419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.